Tate & Lyle in talks with Ingredion over USD 3.6B takeover
The talks follow a series of earlier approaches from Ingredion, and both companies stress that there is no certainty that a formal offer will ultimately be made.
USA – British ingredient major Tate & Lyle has confirmed that it is in takeover discussions with its US‑based rival Ingredion over a potential all‑cash deal valued at £2.74 billion (USD 3.56 billion).
This move underscores a major consolidation move in the speciality-ingredients sector amid growing crossover into personal care and cosmetics.
According to Tate & Lyle, the indicative offer is structured at up to 615 pence per Tate & Lyle share, combining a base cash consideration of 595 pence per share with an additional element of up to 20 pence per share linked to dividends.
This dividend‑linked element is split into up to 13 pence for the final dividend and up to 7 pence for the interim, both subject to board and shareholder approvals, effectively capping the total implied value at about £2.74 billion (USD 3.56 billion) based on Tate & Lyle’s 445.4 million shares in issue.
Under the UK Takeover Code, Ingredion must either announce a firm intention to make an offer or confirm that it will not proceed by 11 June 2026, unless that deadline is extended.
The Tate & Lyle board has said it is currently evaluating the indicative proposal as part of its ongoing strategic review, noting that due diligence is underway and that the outcome remains uncertain.
This structure has already triggered a strong market reaction, with Tate & Lyle’s stock price surging around 55% on the news, while Ingredion’s shares dipped slightly as investors weighed the cost and integration risks of absorbing a London‑listed peer.
Although both companies are best known for starches, sweeteners, and other food- and beverage‑focused systems, the potential merger is being framed as a strategic move to deepen their footprint in speciality ingredients increasingly used in cosmetics.
Tate & Lyle has actively shifted away from its traditional sugar business, building texture systems, clean‑label solutions, and nature‑derived formulations that are being marketed to personal care and beauty brands seeking plant‑based, multifunctional, and “clean‑label” alternatives to synthetic thickeners.
Tate & Lyle has recently partnered with industry‑insight platforms such as Personal Care Insights and Innova Market Insights on webinars highlighting naturally derived alternatives to conventional skincare thickeners, reinforcing its positioning in higher‑margin, innovation‑driven segments.
The company’s 2024 acquisition of CP Kelco for USD 1.8 billion further broadened its portfolio of fermentation‑derived ingredients, including citrus peel and seaweed, materials now being explored for cosmetic actives and texturants.
On the other hand, Ingredion already supplies biomaterials and starch‑based technologies that function as texture modifiers and natural‑derived alternatives in personal care formulations, overlapping with Tate & Lyle’s emerging beauty‑oriented offerings.
Analysts argue that combining the two portfolios would allow for faster migration from lower‑margin, mature starch and sweetener categories toward higher‑growth speciality-ingredient segments, where pricing power and innovation can support better profitability.
Sign up to receive our email newsletters with the latest news updates and insights from Africa and the World HERE.
